Correlative/special studies

PROCEDURE2 trials

Sponsors

Beth Christian, Ohio State University Comprehensive Cancer Center

Conditions

LymphomaRecurrent Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer

Phase 1

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

CompletedNCT00989586

Beth ChristianLymphoma

Start: 2009-09-30End: 2015-09-30Updated: 2017-02-06

Unknown Phase

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

CompletedNCT01478477

Ohio State University Comprehensive Cancer CenterRecurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer +4

Start: 2011-10-04End: 2014-01-09Updated: 2023-02-27

Related Papers

Abstract P1-09-03: Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: A randomized placebo-controlled pilot study

Cancer Research2015-05-012 citations